publicações selecionadas
-
documento
- Hexokinase II (HKII) as prognostic biomarker and target for bladder cancer therapy 2022
- Metabolic remodelling in cisplatin-resistant bladder cancer 2020
- Cisplatin-resistant urothelial bladder cancer cells undergo metabolic reprogramming 2019
- Cisplatin-resistant urothelial bladder cancer cells undergo metabolic reprogramming. 2019